Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) Assets Average (2017 - 2025)

ENDRA Life Sciences has reported Assets Average over the past 5 years, most recently at $14.1 million for Q4 2021.

  • Quarterly Assets Average rose 99.55% to $14.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $14.1 million through Dec 2021, up 99.55% year-over-year, with the annual reading at $10.8 million for FY2021, 35.75% up from the prior year.
  • Assets Average was $14.1 million for Q4 2021 at ENDRA Life Sciences, down from $16.3 million in the prior quarter.
  • Over five years, Assets Average peaked at $18.1 million in Q2 2021 and troughed at $517943.5 in Q1 2017.
  • The 5-year median for Assets Average is $5.2 million (2018), against an average of $6.8 million.
  • The largest YoY upside for Assets Average was 847.38% in 2018 against a maximum downside of 71.88% in 2018.
  • A 5-year view of Assets Average shows it stood at $6.8 million in 2017, then tumbled by 37.41% to $4.3 million in 2018, then increased by 26.74% to $5.4 million in 2019, then soared by 30.9% to $7.1 million in 2020, then soared by 99.55% to $14.1 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Assets Average are $14.1 million (Q4 2021), $16.3 million (Q3 2021), and $18.1 million (Q2 2021).